HomeALPMY • OTCMKTS
add
Astellas Pharma ADR Representing 1 Ord Shs
Previous close
$11.00
Day range
$10.64 - $11.13
Year range
$8.37 - $11.88
Market cap
3.15T JPY
Avg Volume
143.47K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (JPY) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 524.32B | 13.37% |
Operating expense | 325.88B | -4.65% |
Net income | 79.21B | 120.60% |
Net profit margin | 15.11 | 94.72% |
Earnings per share | — | — |
EBITDA | 140.20B | 59.23% |
Effective tax rate | 23.97% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 287.05B | -2.03% |
Total assets | 3.45T | -0.35% |
Total liabilities | 1.84T | -4.89% |
Total equity | 1.61T | — |
Shares outstanding | 1.79B | — |
Price to book | 0.01 | — |
Return on assets | 6.85% | — |
Return on capital | 9.83% | — |
Cash Flow
Net change in cash
| (JPY) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 79.21B | 120.60% |
Cash from operations | 227.76B | 251.42% |
Cash from investing | -13.46B | 17.87% |
Cash from financing | -144.75B | -166.37% |
Net change in cash | 71.66B | 821.24% |
Free cash flow | 195.05B | 347.45% |
About
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Founded
Apr 1, 2005
Headquarters
Website
Employees
13,643
